ArticleJournal for immunotherapy of cancer2019

PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors.

Guillaume Beyrend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.